Creatine Benefits: Strength, Muscle, Brain and Healthy Aging Evidence

Creatine benefits are often presented as one long list, but the human evidence is not equally strong for every claim. The clearest benefits are still in resistance training and repeated high-intensity performance. Evidence for healthy aging is promising but more conditional, while brain and cognitive effects remain mixed.

The useful way to judge creatine is by outcome: what population was studied, what dose was used, whether exercise was part of the intervention and whether the endpoint was something clinically meaningful or just a surrogate marker.

Creatine benefits by strength of evidence

Outcome	Evidence position	Best interpretation
Strength with resistance training	Strongest	One of the most reproducible benefits, supported by large modern meta-analyses.
Lean mass with resistance training	Strong	Average lean-mass gain is higher with creatine, but early body-weight change also includes water.
Repeated high-intensity performance	Strong	Fits creatine's phosphocreatine mechanism better than long steady-state endurance.
Healthy aging strength	Moderate	Useful as an adjunct to resistance training; newer older-adult meta-analysis shows a small additional strength effect.
Cognition and sleep-loss resilience	Promising but mixed	Positive signals exist, especially under metabolic stress, but reviews and regulatory assessments do not support a universal nootropic claim.
Disease-specific treatment	Condition-specific	Clinical trials should be interpreted by disease, dose and endpoint rather than generalized into a broad treatment claim.

For male-specific questions, see creatine for men. For timing of results, see how long creatine takes to work.

Which creatine benefits are best established?

Outcome	Evidence level	Key qualifier
Muscle creatine saturation	Established	Direct biopsy evidence; loading changes speed, not the eventual goal.
Strength with resistance training	Strong	Benefits are modest additions to training, not a replacement for training.
Lean mass with resistance training	Strong to moderate	Early water gain and longer-term tissue adaptation must be separated.
Repeated high-intensity performance	Strong	Most relevant to short, repeated efforts rather than steady endurance.
Older-adult strength	Moderate	Best supported when combined with resistance training.
Postmenopausal lean mass / leg strength	Moderate	Recent pooled benefits are small and training-dependent; bone-density effects remain uncertain.
Memory / cognition	Mixed	Some positive pooled signals, but methods, brain-creatine measurement and outcomes vary.
Direct fat loss, dementia prevention or general anti-aging	Not established	Do not extrapolate from muscle bioenergetics or disease-specific pilot studies.

1. Creatine can improve strength during resistance training

Strength is one of the most consistent creatine outcomes. A large 2025 systematic review and meta-analysis covering 69 studies and 1,937 participants reported small but statistically significant improvements in several upper- and lower-body strength and power outcomes when creatine was used, particularly alongside resistance training. Not every test improved, which is important: creatine is an adjunct to training, not an instant strength drug.

A 2026 three-level meta-analysis of 63 studies similarly found improvements in upper- and lower-body strength when creatine was combined with resistance training. These effects make biological sense because greater intramuscular phosphocreatine can support repeated high-intensity work and, over time, potentially allow a slightly larger training stimulus.

2. Creatine can add lean mass during resistance training

A 2024 meta-analysis focused on resistance-training body composition found that creatine added approximately 1.14 kg of lean body mass compared with resistance training alone. Another dose-response review of 143 trials found smaller average increases in body mass and fat-free mass across broader protocols. Differences between reviews reflect populations, study methods and whether resistance training was required.

Not all early weight gain is new contractile muscle. Creatine increases intracellular water as muscle creatine rises, particularly during loading. Over longer training studies, however, the additional lean-mass signal is not explained solely by a few days of water retention.

3. Creatine helps repeated high-intensity performance more than endurance

Creatine's energy-system role makes it most relevant to repeated sprints, maximal or near-maximal efforts and resistance exercise. This does not mean it improves every type of athletic performance. A 2023 meta-analysis of 13 placebo-controlled studies in trained people found no significant improvement in endurance performance.

This is an important boundary: a supplement can have a strong evidence base for one energy system without being a universal ergogenic aid.

4. Creatine may support healthy aging strength

Older adults are a major area of current interest. A 2026 three-level meta-analysis of 11 randomized trials found that adding creatine to resistance training produced a small improvement in muscle strength in adults aged 60 and older. Evidence certainty was moderate for strength but lower for muscle mass and physical function, where the pooled additional benefits were not statistically clear.

For someone concerned about age-related loss of strength, this makes creatine a plausible adjunct to progressive resistance training. It does not replace adequate protein intake, balance training, treatment of osteoporosis or evaluation of unexplained weakness.

5. Benefits in women are plausible, but female-specific evidence is smaller

General creatine physiology applies to women, but the female-specific performance literature is much smaller. A 2025 systematic review identified 27 studies in active females and found that most measured performance outcomes did not improve versus placebo. The authors highlighted major heterogeneity and weak handling of female-specific physiological factors.

At the same time, a female safety meta-analysis involving 951 participants did not find higher rates of serious adverse outcomes, gastrointestinal events or renal/hepatic complications. In postmenopausal women, a 2026 meta-analysis suggests that creatine—especially at 5 g/day or more alongside resistance training—may modestly support lean mass and leg-press strength, while bone-mineral-density effects remained uncertain.

See our creatine for women guide for life-stage-specific evidence.

6. Creatine and cognition: promising, but not settled

The cognitive evidence deserves more caution than social-media headlines usually give it. A 2024 meta-analysis reported benefits in memory and selected attention or processing-speed measures. A separate 2024 systematic review concluded that cognitive results were equivocal overall despite evidence that supplementation can increase brain creatine.

A memory-specific meta-analysis reported a small pooled benefit, potentially larger in older adults, but later methodological criticism means that estimate should not stand alone. A 2026 systematic review in older adults found mostly positive associations, yet only two of six included studies were double-blind interventions. The responsible conclusion is that creatine may help certain cognitive domains or stressed populations, but broad “brain booster” claims outrun the current evidence.

7. Creatine may have medical applications—but that is different from self-treatment

Creatine has been studied in conditions ranging from type 2 diabetes to depression and neurological disease. A small diabetes RCT found improved HbA1c when 5 g/day creatine was added to exercise training, and a trial in women with major depression found faster symptom improvement when creatine was added to escitalopram. These studies are scientifically interesting but do not make creatine a substitute for medical treatment.

What creatine does not reliably do

• It does not consistently improve endurance performance.
• It has not been shown to cause direct fat loss independent of diet and training.
• It is not proven to prevent dementia or treat depression in the general population.
• It is not an anabolic steroid.
• Alternative forms have not consistently outperformed creatine monohydrate.
• 2025 muscle-strength systematic review and meta-analysis
• Type 2 diabetes randomized trial

How to get the benefits studied in trials

For most healthy adults, a daily creatine monohydrate dose in the 3–5 g range is the simplest evidence-aligned approach. Loading can raise stores faster but is optional. For muscle and strength outcomes, combining creatine with progressive resistance training matters more than obsessing over the exact minute of ingestion.

For paper-level study details, see our 89-paper Creatine Data Center.

From evidence to product choice: Our DoNotAge Creatine Monohydrate review checks whether the finished product delivers the simple monohydrate format and practical dose used across this evidence base.

Clinical applications remain condition-specific

The Creatine Data Center also includes emerging clinical literature outside sports nutrition. A 2026 systematic review of eight small studies in rheumatologic and chronic musculoskeletal-pain populations found possible strength, muscle-mass and quality-of-life benefits in selected settings—often when creatine was combined with exercise—but pain and inflammatory outcomes were inconsistent. These disease-specific findings should not be generalized into a broad treatment claim.

Continue by outcome

Start with what creatine monohydrate is, then go deeper into performance, muscle growth, brain and cognition, healthy aging or women's evidence.

Fresh 2026 midlife trial: 10 g/day with and without exercise

A newly published 12-week randomized supplement trial adds a useful piece of evidence that most generic creatine-benefit pages do not yet cover. Sixty-four sedentary adults aged 45–65 completed the study. Within self-selected exercise/diet and non-exercise strata, participants were randomized to 10 g/day creatine monohydrate or placebo.

Creatine increased lean tissue and selected strength/endurance outcomes in the non-exercise stratum; during the exercise plus weight-loss program, creatine was associated with greater improvement in body-fat percentage and several training outcomes. Selected cognitive and metabolic markers also changed, but the authors explicitly describe individual cognitive and biomarker findings as exploratory.

The design matters: exercise participation itself was not randomized, there were many secondary outcomes, follow-up lasted 12 weeks, and AlzChem supplied the study supplements and funded homocysteine assays. The result is useful evidence for midlife creatine use—not proof that creatine replaces resistance training or treats metabolic disease. Read the full research record.

2026 evidence expansion: more data, but not one universal effect

The newest evidence reinforces why creatine benefits should be separated by endpoint. A mixed-sex trial improved Wingate power without improving cognition; a 103-person older-adult trial found selected additive effects within a larger resistance-training program; and a lower-dose sleep-deprivation study reported cognitive protection under acute metabolic stress. Meanwhile, a women’s musculoskeletal meta-analysis did not show robust pooled muscle-mass or bone benefits across mixed supplement classes, and the EFSA cognition opinion concluded that a general healthy-adult cognitive cause-and-effect claim had not been established.

More studies therefore strengthen the creatine evidence base without making every claim stronger. The best-supported benefits remain resistance-training and high-intensity outcomes, while cognition, rehabilitation, women’s health and aging require outcome-specific interpretation.

Bottom line

The strongest creatine benefits are increased muscle creatine availability and modest improvements in strength, training adaptations and lean mass when paired with resistance exercise. Benefits in older adults and postmenopausal women are increasingly supported but still depend on training context. Cognitive benefits remain plausible rather than universally proven.

Research used in this guide

• 2025 strength and power meta-analysis
• 2024 body-composition meta-analysis
• 2026 older-adult meta-analysis
• 2024 cognition meta-analysis
• 2024 skeptical cognition review